Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Maravai LifeSciences Holdings, Inc. (MRVI) had Stock-Based Compensation of $30.17M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$49.87M |
|
$-35.68M |
|
$37.02M |
|
$12.84M |
|
$108.66M |
|
$-58.80M |
|
$-4.21M |
|
$-63.01M |
|
$-63.01M |
|
$-63.02M |
|
$-63.02M |
|
$-63.02M |
|
$-63.02M |
|
$-58.80M |
|
$-86.54M |
|
144.36M |
|
144.36M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$296.25M |
|
$151.48M |
|
$474.33M |
|
$770.58M |
|
$44.92M |
|
$316.47M |
|
$352.95M |
|
$397.87M |
|
$372.71M |
|
$91.74M |
|
$372.71M |
|
256.01M |
|
| Cash Flow Statement Financials | |
$-57.57M |
|
$-31.41M |
|
$-16.50M |
|
$322.40M |
|
$216.89M |
|
$-105.51M |
|
|
Stock-Based Compensation |
$30.17M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.60 |
|
-- |
|
-- |
|
0.46 |
|
0.86 |
|
25.75% |
|
-117.91% |
|
-117.91% |
|
-- |
|
-126.36% |
|
-71.55% |
|
$-70.72M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.91 |
|
1.96 |
|
46.02 |
|
-16.91% |
|
-68.69% |
|
-8.18% |
|
-9.14% |
|
$1.46 |
|
$-0.49 |
|
$-0.40 |
|